Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | DPP4 | P27487 | 5/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | PGR | P06401 | 1/20 | 0.30 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.30 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.30 |
| ▸ | HTR1A | P08908 | 1/20 | 0.30 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.30 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.30 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.30 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.30 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.30 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.30 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13577874 | 0.83 | ALOX15 (0.39) | ALDH1A1LMNAHSD17B10DPP4MAPT | |
| SCHEMBL15623785 | 0.78 | DPP4 (0.42) | ALDH1A1LMNAHSD17B10DPP4MAPT | |
| SCHEMBL23125484 | 0.77 | ALDH1A1 (0.37) | ALDH1A1LMNAHSD17B10MEN1KMT2A | |
| SCHEMBL19425739 | 0.77 | SLC7A5 (0.41) | ALDH1A1LMNAHSD17B10DPP4MEN1 | |
| SCHEMBL8288611 | 0.77 | SLC7A5 (0.41) | ALDH1A1LMNAHSD17B10DPP4MEN1 | |
| SCHEMBL17833247 | 0.76 | DPP4 (0.33) | DPP4 | |
| SCHEMBL17833080 | 0.76 | DPP4 (0.33) | DPP4 | |
| SCHEMBL15574916 | 0.76 | ALDH1A1 (0.40) | ALDH1A1LMNAHSD17B10MEN1KMT2A | |
| SCHEMBL15574917 | 0.76 | ALDH1A1 (0.40) | ALDH1A1LMNAHSD17B10MEN1KMT2A | |
| SCHEMBL8004357 | 0.76 | ALOX15 (0.44) | ALDH1A1LMNAHSD17B10DPP4MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170342064-A1 | COMPOUNDS FOR THE TREATMENT OF CANCER | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2017-11-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170342064-A1 | COMPOUNDS FOR THE TREATMENT OF CANCER | MPST, TK1, BRCA1 | ALDH1A1 1557/4885LMNA 1593/4885HSD17B10 4180/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.